Fosun International has issued a revenue warning, projecting a loss attributable to homeowners of the guardian firm of between RMB21.5 billion and RMB23.5 billion for the yr ending December 31, 2025. The loss is primarily because of one-off non-cash impairment provisions and worth revaluations on sure actual property tasks and goodwill of non-core enterprise segments.
The firm attributes the substantial e book loss to the continued downturn in the true property business, which has pressured its actual property enterprise section. Additionally, Fosun has made impairment provisions on goodwill and intangible belongings of sure non-core enterprise segments, reflecting adjustments in market situations.
Despite the impairments, Fosun emphasizes that the changes is not going to influence the corporate’s total operations and money flows. Analysts view the impairments as a prudent monetary measure to clear historic burdens, sustaining that they don’t have an effect on the corporate’s working money flows or long-term funding worth. Fosun’s asset base stays stable, with web belongings nonetheless close to the RMB100 billion degree.
According to Fosun’s 2024 annual report, web belongings attributable to homeowners of the guardian had been RMB118.103 billion as of December 31, 2024. Based on the mid-point of the anticipated loss, web belongings could be roughly RMB95.603 billion after deduction. Even on the higher finish of the loss estimate, web belongings would stay at roughly RMB94.603 billion.
The impairments are primarily concentrated in the true property section and the goodwill of non-core companies. These changes align with Fosun’s technique of streamlining and specializing in core companies. The firm notes that its core belongings have appreciated and realized worth, offsetting the influence of impairments and probably contributing to web asset development.
Fosun’s core enterprise segments, together with prescribed drugs and healthcare, in addition to insurance coverage and finance, delivered robust efficiency in 2025 and have maintained momentum into 2026. In the modern drug section, Fosun’s world market alternatives have expanded, highlighted by a licensing settlement with Pfizer valued at over US$2 billion and a strategic cooperation with Clavis Bio value as much as US$7.25 billion.
In the insurance coverage section, Fosun’s Fidelidade recorded a web revenue of €170 million for the primary three quarters of 2025, a year-on-year improve of 11.7%. Peak Reinsurance reported a web revenue of US$88.8 million for the primary half of 2025. Domestic insurance coverage corporations additionally confirmed substantial development in premium earnings and web revenue for the yr.
In the tourism and tradition section, Fosun’s companies achieved robust outcomes, with Club Med’s resorts in China reporting a 90% occupancy price in the course of the Spring Festival vacation, and Atlantis Sanya recording its greatest efficiency on report with whole income of over RMB124 million.
Fosun’s resolution to acknowledge a considerable one-off non-cash e book loss is seen as a proactive step to clear dangers and advance its technique of specializing in core companies. The firm has additionally signaled confidence by growing share repurchase efforts, planning to repurchase shares value as much as HK$1 billion on the open market.